MedTrace Logo

Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea

NCT06582043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-02-28

No results posted yet for this study

Summary

Multicentric and double-blind randomised comparative clinical study in Argentina and Brazil. Under dermatological and ophthalmological control 4 visits: inclusion \[Day(D)0\], D28, D56, D84 Ethical committee required.

Conditions

  • Rosacea
  • Redness
  • Telangiectasia
  • Flushing
  • Pustular Acne
  • Papule Pruritic

Interventions

OTHER

SCARCr tester 1

Twice daily

OTHER

Placebo

Twice daily

Sponsors & Collaborators

  • NAOS Argentina S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2025-01-09
Completion
2025-02-06

Countries

  • Argentina
  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06582043 on ClinicalTrials.gov